Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06168305 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease

Study acronym: GENOSS-MV
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary endpoint revised Trial status: Recruiting to Enrolling by Invitation · Interventions: Genoss DES (Device) to GENOSS® DES Sirolimus Eluting Coronary Stent System (Device) · Secondary endpoints: 1 to 10 · 4 morev2 Show 7 more changesShow less
    • Trial status: Recruiting to Enrolling by Invitation
    • Interventions: Genoss DES (Device) to GENOSS® DES Sirolimus Eluting Coronary Stent System (Device)
    • Secondary endpoints: 1 to 10
    • Site details revised
    • Study title revised
    • Study arms: 0 to 1
    • Eligibility criteria expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators intend to establish a multicenter prospective observational study by enrolling and tracking patients with multivessel coronary artery disease (MVCAD) using Genoss DES, a device manufactured with pure domestic technology. The study aims to evaluate the efficacy and safety of Genoss DES in MVCAD patients.
Trial Details
NCT Number NCT06168305
Lead Sponsor Genoss Co., Ltd.
Conditions Percutaneous Coronary Intervention, Multivessel Coronary Artery Disease
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov